What differential diagnoses and workup should be considered for a patient with hemoglobin 11 g/dL, low mean corpuscular hemoglobin (MCH) 25.5 pg, and low mean corpuscular hemoglobin concentration (MCHC) 30.1 g/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Think Iron Deficiency Anemia First

With hemoglobin 11 g/dL, MCH 25.5 pg (low), and MCHC 30.1 g/dL (low), you are looking at hypochromic microcytic anemia, and iron deficiency anemia is the most likely diagnosis that requires immediate workup.

Understanding Your Red Cell Indices

Your patient has:

  • Mild anemia (Hb 11 g/dL - below WHO threshold of 12 g/dL for non-pregnant women, 13 g/dL for men)
  • Hypochromia (low MCH at 25.5 pg, normal ~27-33 pg) - red cells contain less hemoglobin
  • Low MCHC (30.1 g/dL, normal ~32-36 g/dL) - reduced hemoglobin concentration within cells

MCH is actually more reliable than MCV for detecting iron deficiency because it's less dependent on the analyzer used and storage conditions, and it decreases in both absolute and functional iron deficiency 1.

Primary Differential Diagnosis

1. Iron Deficiency Anemia (Most Likely)

This is your leading diagnosis. The combination of low MCH and low MCHC is classic for IDA 1.

Immediate workup:

  • Serum ferritin - your single best test 1
    • <15 μg/L = iron deficiency (99% specific)
    • <30 μg/L = low iron stores
    • <45 μg/L = consider IDA even with inflammation (92% specific)
    • 150 μg/L = rules out absolute iron deficiency even with inflammation 1

  • Transferrin saturation if ferritin is equivocal
  • Consider therapeutic trial: Hb rise ≥10 g/L within 2 weeks strongly suggests IDA even with equivocal labs 1

If IDA confirmed, investigate the source:

  • GI blood loss (most common in adults)
  • Menstrual losses
  • Dietary insufficiency
  • Malabsorption

2. Thalassemia Trait

Critical pitfall: Thalassemia can mimic IDA with similar indices but requires different management.

When to suspect thalassemia over IDA:

  • MCH disproportionately low for degree of anemia
  • Normal or elevated RBC count (despite low Hb)
  • Family history or appropriate ethnicity (Mediterranean, Asian, African descent)
  • Normal iron studies 1

Action: If iron studies are normal with persistent microcytosis/hypochromia, order hemoglobin electrophoresis 1. Recent data shows MCH ≤21.9 pg suggests beta-thalassemia trait over HbE trait with >90% sensitivity 2, though your patient's MCH of 25.5 pg is higher.

3. Combined Iron and B12 Deficiency

This is an underrecognized entity that can present with microcytic indices despite B12 deficiency (which typically causes macrocytosis).

Red flag: Elevated platelet count with low MCH. A platelet/MCH ratio >12 has 74.6% sensitivity for combined deficiency 3.

Action: If platelets are elevated or clinical suspicion exists (malabsorption, dietary restrictions, gastric surgery), check B12 and folate levels alongside iron studies.

Common Pitfalls to Avoid

  1. Don't assume microcytosis = iron deficiency without checking ferritin - you'll miss thalassemia and waste time/resources on inappropriate GI investigations 1

  2. Don't use ferritin alone in inflammatory conditions - ferritin is an acute phase reactant. If CRP is elevated or chronic disease present, use the 45 μg/L cutoff instead of 30 μg/L 1

  3. Don't ignore normal ferritin if clinical suspicion is high - functional iron deficiency can occur with inflammation/chronic disease. Consider transferrin saturation or therapeutic trial 1

  4. Don't forget to look at the platelet count - unexpectedly high platelets with low MCH should trigger B12 testing 3

Practical Algorithm

  1. Check serum ferritin first (with CBC review for RBC count and platelets)

    • Low (<30-45 μg/L) → Diagnose IDA, investigate source
    • Normal but high platelets → Add B12/folate
    • Normal with appropriate ethnicity → Hemoglobin electrophoresis
  2. If ferritin equivocal (30-150 μg/L):

    • Check CRP/inflammatory markers
    • Consider transferrin saturation
    • Or proceed with therapeutic iron trial (simpler, highly diagnostic) 1
  3. Once IDA confirmed, investigate the cause:

    • Men and non-menstruating women: Assume GI loss until proven otherwise
    • Premenopausal women: Consider menstrual losses but don't ignore GI pathology
    • Consider endoscopy based on severity and risk factors 1

Related Questions

What is the likely diagnosis and appropriate next steps for a CBC with RBC count 5.46 ×10^12/L, mean corpuscular volume 73.6 fL, mean corpuscular hemoglobin 22.5 pg, mean corpuscular hemoglobin concentration 30.6 g/dL, and red cell distribution width 15.5%?
Given a CBC showing normal white‑blood‑cell count and platelets but mild normocytic anemia (hemoglobin 11.7 g/dL, hematocrit 36.9 %, red‑cell count 4.27 M/µL, MCV 86.4 fL, MCH 27.4 pg, MCHC 31.8 g/dL, RDW 15.5 %), what is the likely etiology and what further evaluation or treatment is recommended?
What are the normal laboratory reference ranges for anemia (hemoglobin, hematocrit, red blood cell count, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration) in adults and children?
How should I interpret and manage a patient with hemoglobin 108 g/L, mean corpuscular hemoglobin concentration 297 g/L, and platelet count 437 ×10⁹/L?
Given a complete blood count showing hemoglobin 5.7 g/dL, hematocrit 22.6 %, mean corpuscular volume 69.1 fL, mean corpuscular hemoglobin 17.4 pg, mean corpuscular hemoglobin concentration 25.2 g/dL, and red cell distribution width 20.1 %, does the patient need intravenous iron infusion or oral iron supplementation?
Which high‑intensity statin should be started in a 48‑year‑old African American male with a 10‑year ASCVD risk of 17.9% and newly diagnosed hypertension?
Can I increase the oral diltiazem dose for atrial fibrillation?
What patient education should be provided for hydroxyurea therapy in sickle cell disease, including dosing, administration, monitoring, side effects, and safety precautions?
Can I take two 120 mg extended‑release tablets instead of one 240 mg tablet?
Is there a sensory intercostal nerve along the inferior margin of the left ribs?
What are the indications, insertion technique, maintenance, and removal recommendations for an indwelling (Foley) urinary catheter?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.